HIV-1 infects immature dendritic cells (iDCs), but infection is inefficient compared with activated CD4+ T cells and only involves a small subset of iDCs. We analyzed whether this could be attributed to specific cellular restrictions during the viral life cycle. To study env-independent restriction to HIV-1 infection, we used a single-round infection assay with HIV-1 pseudotyped with vesicular stomatitis virus G protein (HIV-VSVG). Small interfering RNA–mediated depletion of APOBEC3G/3F (A3G/3F), but not TRIM5α, enhanced HIV-1 infection of iDCs, indicating that A3G/3F controls the sensitivity of iDCs to HIV-1 infection. Furthermore, sequences of HIV reverse transcripts revealed G-to-A hypermutation of HIV genomes during iDC infection, demonstrating A3G/3F cytidine deaminase activity in iDCs. When we separated the fraction of iDCs that was susceptible to HIV, we found the cells to be deficient in A3G messenger RNA and protein. We also noted that during DC maturation, which further reduces susceptibility to infection, A3G levels increased. These findings highlight a role for A3G/3F in explaining the resistance of most DCs to HIV-1 infection, as well as the susceptibility of a fraction of iDCs. An increase in the A3G/3F-mediated intrinsic resistance of iDCs could result in a block of HIV infection at its mucosal point of entry.
Skip Nav Destination
Article navigation
25 December 2006
Article|
December 04 2006
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
Marjorie Pion,
Marjorie Pion
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Search for other works by this author on:
Angela Granelli-Piperno,
Angela Granelli-Piperno
3Laboratory of Cellular Physiology and Immunology and
4Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10021
Search for other works by this author on:
Bastien Mangeat,
Bastien Mangeat
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Search for other works by this author on:
Romaine Stalder,
Romaine Stalder
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Search for other works by this author on:
Rafael Correa,
Rafael Correa
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Search for other works by this author on:
Ralph M. Steinman,
Ralph M. Steinman
3Laboratory of Cellular Physiology and Immunology and
4Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10021
Search for other works by this author on:
Vincent Piguet
Vincent Piguet
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Search for other works by this author on:
Marjorie Pion
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Angela Granelli-Piperno
3Laboratory of Cellular Physiology and Immunology and
4Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10021
Bastien Mangeat
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Romaine Stalder
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Rafael Correa
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
Ralph M. Steinman
3Laboratory of Cellular Physiology and Immunology and
4Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10021
Vincent Piguet
1Department of Dermatology and Venereology and
2Department of Microbiology and Molecular Medicine, University Hospital and Medical School of Geneva, 1211 Geneva, Switzerland
CORRESPONDENCE Vincent Piguet: [email protected]
Abbreviations used: A3F and A3G, APOBEC3F and APOBEC3G, respectively; iDC, immature DC; JT, Jurkat CD4+ T cell; LMM, low molecular mass; LV, lentiviral vector; mDC, monocyte-derived DC; MOI, multiplicity of infection; mRNA, messenger RNA; P, pellet; siRNA, small interfering RNA; SN, supernatant; T5α, Trim5α; VSVG, vesicular stomatitis virus G.
Received:
July 18 2006
Accepted:
November 13 2006
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2006
J Exp Med (2006) 203 (13): 2887–2893.
Article history
Received:
July 18 2006
Accepted:
November 13 2006
Citation
Marjorie Pion, Angela Granelli-Piperno, Bastien Mangeat, Romaine Stalder, Rafael Correa, Ralph M. Steinman, Vincent Piguet; APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection . J Exp Med 25 December 2006; 203 (13): 2887–2893. doi: https://doi.org/10.1084/jem.20061519
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement